{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18652", "batch_size": 200, "batch_pos": 155, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, critical alert phrase, superlative + harm noun, or intensifier + harm noun.", "method": "llm_batch", "batch_id": "batch_2_4768", "batch_size": 200, "batch_pos": 150, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "No moderate verb from the approved list is present.", "method": "llm_batch", "batch_id": "batch_3_18916", "batch_size": 200, "batch_pos": 121, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_20200", "batch_size": 200, "batch_pos": 117, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment discusses trial timing but contains no explicit calming cues.", "method": "llm_batch", "batch_id": "batch_5_5780", "batch_size": 200, "batch_pos": 112, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment contains numbers/dates but no minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_16228", "batch_size": 200, "batch_pos": 100, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_3036", "batch_size": 200, "batch_pos": 98, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment describes a future development/preparedness step: 'late-stage testing would begin'.", "method": "llm_batch", "batch_id": "batch_8_18340", "batch_size": 200, "batch_pos": 70, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
